Landmark Study

New Hope In Fight Against One of the Deadliest Cancers

Landmark Multi-Year Study Finds Biofield Therapy Slows Pancreatic Cancer Growth and Spread

A rigorous new study at MD Anderson Cancer Center reveals that biofield therapy (BT)ā€”a non-invasive, practitioner-administered therapy also known as energy medicineā€”can significantly slow the growth and spread of pancreatic cancer in pre-clinical models. The findings, published in Cancer Medicine, mark one of the most comprehensive investigations to date on the biological effects of BT.

Conducted over four years, the preclinical study demonstrated that BT significantly reduced cancer cell proliferation and metastasis. Notably, it reduced metastasis to the liver in mouse models by more than 50% in repeated studies.

Landmark Study

New Hope In Fight Against One of the Deadliest Cancers

Landmark Multi-Year Study Finds Biofield Therapy Slows Pancreatic Cancer Growth and Spread

A rigorous new study at MD Anderson Cancer Center reveals that biofield therapy (BT)ā€”a non-invasive, practitioner-administered therapy also known as energy medicineā€”can significantly slow the growth and spread of pancreatic cancer in pre-clinical models. The findings, published in Cancer Medicine, mark one of the most comprehensive investigations to date on the biological effects of BT.

Conducted over four years, the preclinical study demonstrated that BT significantly reduced cancer cell proliferation and metastasis. Notably, it reduced metastasis to the liver in mouse models by more than 50% in repeated studies.

Get full access to the study summary and research article.

Sign up to learn more about the MD Anderson cancer study and get early access to emerging science bringing biofield therapies into the mainstream.